[Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry].
Aitor UribarriIván J Núñez-GilÁlvaro AparisiRamón Arroyo-EspligueroCharbel Maroun EidRodolfo RomeroVíctor M Becerra-MuñozGisela FeltesMaría MolinaMarcos García-AguadoEnrico CerratoThamar Capel-AstruaEmilio Alfonso-RodríguezAlex F Castro-MejíaSergio Raposeiras-RoubínCarolina EspejoNerea Pérez-SoléAlfredo BardajíFrancisco MarínÓscar Fabregat-AndrésFabrizio D'ascenzoFrancesco SantoroIbrahim AkinVicente EstradaAntonio Fernández-OrtizCarlos Macayanull nullPublished in: Revista espanola de cardiologia (2021)
AF in COVID-19 patients is associated with a higher number of complications and 60-day mortality. The CHA2DS2-VASc score may be a good risk marker in COVID patients but does not predict their embolic risk.